Scholars

Instructional Associate Professor

Positions:

Instructional Associate Professor, College of Medicine, Health Science Center

Research Areas:

Clinical medicine--Research, Biochemical markers, Biomarkers, Genomics, Medical records--Data processing, Prostate--Cancer, Data mining, Cancer

UN Sustainable Development Goals:

Single Page Bio

Profile Summary

kamlesh.yadav@tamu.edu

Co-author Network

Map of Science

ORCID

0000-0003-3266-7988

UN Sustainable Development Goals:

Research Areas:

Clinical medicine--Research, Biochemical markers, Biomarkers, Genomics, Medical records--Data processing, Prostate--Cancer, Data mining, Cancer

overview

Dr. Yadav's primary interest is in translational research, specifically biomarker discoveries and novel therapeutics in cancer (especially prostate) through a combination of biochemistry and genomics. He is also interested in mining EMRs for personalized diagnosis, prognosis and therapeutics using real worlds evidence (RWE) data coupled with machine-learning/AI-algorithms.

education and training

Memorial Sloan Kettering Cancer Center - (New York, New York, United States), Postdoctoral Training 2014
Ph.D. in Cell and Molecular Biology, New York University School of Medicine - (New York, New York, United States) 2010
M.Tech. in Environmental Engineering and Management, Indian Institute of Technology Kanpur - (Kanpur, Uttar Pradesh, India) 2003
M.Sc. in Biochemistry, Banaras Hindu University - (Varanasi, Uttar Pradesh, India) 2001

selected publications

Academic Articles34

Ayers, K. L., Mullaney, T., Zhou, X., Liu, J. J., Lee, K., Ma, M., ... Chen, R. (2021). Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers.. Oncologist. 26(7), e1226-e1239.
Rayford, W., Beksac, A. T., Alger, J., Alshalalfa, M., Ahmed, M., Khan, I., ... Tewari, A. K. (2021). Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.. Commun Biol. 4(1), 670.
Stockert, J. A., Weil, R., Yadav, K. K., Kyprianou, N., & Tewari, A. K. (2021). Pseudouridine as a novel biomarker in prostate cancer.. Urol Oncol. 39(1), 63-71.
Woo, J., Santasusagna, S., Banks, J., Pastor-Lopez, S., Yadav, K., Carceles-Cordon, M., ... Domingo-Domenech, J. (2020). Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.. J Urol. 204(4), 691-700.
Woo, J., Santasusagna, S., Banks, J., Dominguez-Andres, A., Yadav, K., Pippa, R., ... Domingo-Domenech, J. (2019). Urine extracellular vesicle GATA2 mRNA alone and in a multigene test predicts initial prostate biopsy result. Annals of Oncology. 30, v349-v349.

Chapters1

Tewari, A. K., Stockert, J. A., Yadav, S. S., Yadav, K. K., & Khan, I. (2018). Inflammation and Prostate Cancer.. MATHEMATICAL MODELLING IN EXPERIMENTAL NUTRITION. Cell & Molecular Biology of Prostate Cancer. 41-65. Springer International Publishing.

Conference Papers6

Woo, J., Santasusagna, S., Banks, J., Dominguez-Andres, A., Yadav, K., Pippa, R., ... Domingo-Domenech, J. (2019). Urine extracellular vesicle GATA2 mRNA alone and in a multigene test predicts initial prostate biopsy result. ANNALS OF ONCOLOGY. 30,
Ma, M., Zhou, X., Goldsweig, H., Hahner, N., Han, D., Dietz, M., ... Chen, R. (2019). Analysis of real-world data (RWD) on treatment (tx) sequencing in patients with advanced non-small cell lung cancer (aNSCLC).. Journal of Clinical Oncology. 37(15_suppl), e20642-e20642.
Liu, Z., Ma, M., Grover, K., Li, L. i., Goldsweig, H., Yadav, K., ... Chen, R. (2019). Investigating racial differences in treatment responses through analysis of real-world data (RWD).. Journal of Clinical Oncology. 37(15_suppl), e18141-e18141.
Yadav, K. K., Shameer, K., Stockert, J. A., Elaiho, C., Readhead, B., Yadav, S. S., Dudley, J., & Tewari, A. K. (2018). Abstract B023: Identification and biochemical validation of piperlongumine as a potent therapeutic against neuroendocrine prostate cancer. Poster Presentations - Proffered Abstracts, Abstracts: AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical Research; December 2-5, 2017; Orlando, Florida. b023-b023.
Yadav, K. K., Shameer, K., Readhead, B., Stockert, J. A., Elaiho, C., Yadav, S. S., ... Dudley, J. T. (2017). Abstract 3250: Computational drug repositioning and biochemical validation of piperlongumine as a potent therapeutic agent for neuroendocrine prostate cancer. Cancer Chemistry, Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. 3250-3250.